Farzaneh Esmaily

Ms. Farzaneh Esmaily

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2024
Verified
Journal Article
Open access
PDF file
SPSomayeh Parichehreh-Dizaji
Somayeh Parichehreh-Dizaji
SHSeyed Kianoosh Hosseini
Seyed Kianoosh Hosseini
SDSepideh Borhan Dayani
Sepideh Borhan Dayani
HMHossein Maghsoudi
Hossein Maghsoudi
FEFarzaneh Esmaily
Farzaneh Esmaily
MAMahsa M. Amoli
Mahsa M. Amoli
Background Atherosclerotic lesions are formed as a result of low-density lipoprotein (LDL) accumulation, which is produced by oxidizing enzymes and oxidized phospholipids (OxPL). Phospholipid oxide causes inflammation-inducing activation genes and hyper-inflammation in addition to the initiation of inflammation and expression of Th1 cytokines. Interleukin 12 (IL-12) is one of the most significant stimulants of inflammation and immune responses, among the Th1cytokines. Therefore, it may play a significant role in contributing to atherosclerosis. The quantitative expression of IL-12 mRNA, along with serum OxPL levels, has been analyzed in patients with coronary artery disease (CAD). Methods: Coronary angiography patients, aged 45 to 65 years and referred with chest pain, were examined. The patients were classified into normal coronary arteries (N = 38) and severe three-vessel involvement coronary arteries (N = 41). Molecular testing was performed using real-time PCR. Also, an ELISA test was used to check the OxPl level. Results Expression of IL12 in Individuals with coronary artery disease was increased but was not statistically significant.